Skip to main content

Closed

NTLA: Intellia Therapeutics, Inc. Company Profile & Overview | finqOS

Healthcare · Biotechnology

52W Range

13thpctl

Volume

0.45×avg

Market Cap

1.20BUSD

P/E Ratio

-3.0TTM

Div Yield

-ann

Intellia Therapeutics, Inc.

NTLANASDAQ Global Market·USD·Closed

Intellia Therapeutics, Inc.

NTLANASDAQ·USD·Closed

$10.68

−3.70%

$10.68

−$0.41 (3.70%)

52W Range

13thpctl

Volume

0.45×avg

Mkt Cap

1.20BUSD

P/E

-3.0TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings